Fish oil: clinical trials recruiting now
FDA drug label
- FDA-approved
- Yes. Fish oil appears in the FDA drug-label database. Marketed as Omegaven.
FDA-approved use
Omegaven is indicated as a source of calories and fatty acids in pediatric patients with parenteral nutrition-associated cholestasis (PNAC). Limitations of Use: • Omegaven is not indicated for the prevention of PNAC. It has not been demonstrated that Omegaven prevents PNAC in parenteral nutrition (PN)-dependent patients [see Clinical Studies ( 14 )]. • It has not been demonstrated that the clinical outcomes observed in patients treated with Omegaven are a result of the omega-6: omega-3 fatty acid ratio of the product [see Clinical Studies ( 14 )]. Omegaven is indicated as a source of calories and fatty acids in pediatric patients with parenteral nutrition-associated cholestasis (PNAC). ( 1 ) Limitations of Use: • Omegaven is not indicated for the prevention of PNAC. It has not been demonstrated that Omegaven prevents PNAC in parenteral nutrition (PN)-dependent patients. ( 1 ) • It has not been demonstrated that the clinical outcomes observed in patients treated with Omegaven are a result of the omega-6:omega-3 fatty acid ratio of the product. ( 1 )
Phase breakdown
Conditions being studied
Recruiting trials involving Fish oil
- Fish Oil, Metformin and Heart Health in PCOS
- Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients
- Perinatal Depression & Anxiety (PDA) and Maternal Gut Microbiome
- Prevention of Oxaliplatin-induced Nerve Damage in the Body's Extremities
Common questions
Is Fish oil FDA-approved?
Yes, marketed as Omegaven.
How many recruiting trials involve Fish oil?
4 recruiting trials across 15 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.